News und Analysen
![Sangamo Therapeutics Announces Participation at the Bank of America 2020 Health Care Conference](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Sangamo Therapeutics Announces Participation at the Bank of America 2020 Health Care Conference
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present at the Bank of America 2020 Health Care Conference on Thursday, May 14 at 4:20
![Agilent Awards Trilogy Sciences with a Golden Ticket at LabCentral](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
Agilent Awards Trilogy Sciences with a Golden Ticket at LabCentral
Agilent Technologies Inc. (NYSE: A) announces that biotech startup Trilogy Sciences has been awarded an Agilent Golden Ticket at LabCentral, a leading biotech innovation hub based in Cambridge
![DexCom Prices Offering of Upsized $1.05 Billion of 0.25% Convertible Senior Notes](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
DexCom Prices Offering of Upsized $1.05 Billion of 0.25% Convertible Senior Notes
DexCom, Inc. (Nasdaq: DXCM) (“DexCom”) announced today the pricing of its offering of $1.05 billion aggregate principal amount of 0.25% Convertible Senior Notes due 2025 (the “notes”) in a private
![DexCom Prices Offering of Upsized $1.05 Billion of 0.25% Convertible Senior Notes](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
DexCom Prices Offering of Upsized $1.05 Billion of 0.25% Convertible Senior Notes
DexCom, Inc. (Nasdaq: DXCM) (“DexCom”) announced today the pricing of its offering of $1.05 billion aggregate principal amount of 0.25% Convertible Senior Notes due 2025 (the “notes”) in a private
![CymaBay: April-Empfehlung mit +196% Kursgewinn!](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
CymaBay: April-Empfehlung mit +196% Kursgewinn!
Die Party im No Brainer Club kennt derzeit wieder keine Grenzen. Mit CymaBay Therapeutics (WKN: A116DD) ist der nächste Vervielfacher eingetütet – in kaum mehr als einem Monat!
Die NBC-Experten
![Sangamo Therapeutics Reports Business Highlights and First Quarter 2020 Financial Results](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
Sangamo Therapeutics Reports Business Highlights and First Quarter 2020 Financial Results
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today reported first quarter 2020 financial results and recent business highlights.
“I’m proud of how the Sangamo team has
![Humana Specialty Pharmacy Wins National Award for Third Consecutive Year](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
Humana Specialty Pharmacy Wins National Award for Third Consecutive Year
Humana Specialty Pharmacy has received the Specialty Pharmacy Patient Choice Award in the PBM/Payer category for the third year in a row. The award, presented by Zitter Health Insights, a division
![Humana Announces Additional Bold Goal Communities in Cincinnati and Detroit](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Humana Announces Additional Bold Goal Communities in Cincinnati and Detroit
Humana Inc. (NYSE: HUM) announced today that Cincinnati, Ohio and Detroit, Michigan are the latest additions to its Bold Goal communities. The Bold Goal is Humana’s population health strategy to
![LivaNova to Present at the UBS Virtual Global Healthcare Conference](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
LivaNova to Present at the UBS Virtual Global Healthcare Conference
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced Damien McDonald, Chief Executive Officer, will present at the UBS Virtual Global Healthcare Conference on
![DexCom Announces Proposed Offering of $850.0 Million of Convertible Senior Notes](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
DexCom Announces Proposed Offering of $850.0 Million of Convertible Senior Notes
DexCom, Inc. (Nasdaq: DXCM) (“DexCom”) announced today that it intends to offer, subject to market conditions and other factors, $850.0 million aggregate principal amount of Convertible Senior
![DexCom Announces Proposed Offering of $850.0 Million of Convertible Senior Notes](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
DexCom Announces Proposed Offering of $850.0 Million of Convertible Senior Notes
DexCom, Inc. (Nasdaq: DXCM) (“DexCom”) announced today that it intends to offer, subject to market conditions and other factors, $850.0 million aggregate principal amount of Convertible Senior
![NanoString to Present at the Bank of America Health Care Conference](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
NanoString to Present at the Bank of America Health Care Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present
![Quidel Receives Emergency Authorization for Rapid Antigen COVID-19 Diagnostic Assay](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Quidel Receives Emergency Authorization for Rapid Antigen COVID-19 Diagnostic Assay
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel has
![DexCom, Inc. Announces Change of Location of Annual Meeting of Stockholders to Be Held May 21, 2020](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
DexCom, Inc. Announces Change of Location of Annual Meeting of Stockholders to Be Held May 21, 2020
DexCom, Inc. (NASDAQ:DXCM) today announced that, due to the public health impact of the COVID-19 pandemic, the location of the 2020 Annual Meeting of Stockholders of DexCom, Inc. (the “Company”)
![DexCom, Inc. Announces Change of Location of Annual Meeting of Stockholders to Be Held May 21, 2020](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
DexCom, Inc. Announces Change of Location of Annual Meeting of Stockholders to Be Held May 21, 2020
DexCom, Inc. (NASDAQ:DXCM) today announced that, due to the public health impact of the COVID-19 pandemic, the location of the 2020 Annual Meeting of Stockholders of DexCom, Inc. (the “Company”)
![Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on May 4, 2020 the Compensation Committee of Puma’s Board of Directors approved the grant of inducement
![Acadia Healthcare to Participate in BofA Securities 2020 Health Care Conference](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
Acadia Healthcare to Participate in BofA Securities 2020 Health Care Conference
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the BofA Securities 2020 Health Care Conference, which takes place May 12 – 14, 2020. This
![Premier Inc. Predictive Technology Helps Prepare for Resumption of Elective Procedures by Identifying Surges in COVID-19 Cases and Supply Needs](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
Premier Inc. Predictive Technology Helps Prepare for Resumption of Elective Procedures by Identifying Surges in COVID-19 Cases and Supply Needs
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, is leveraging its technology solutions to help hospitals and health systems across the country anticipate surges in COVID-19
![Gilead Sciences: Remdesivir ist leider kein Allheilmittel](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Gilead Sciences: Remdesivir ist leider kein Allheilmittel
Gilead Sciences (WKN: 885823) ist, langfristig betrachtet, eine der größten Erfolgsgeschichten im Biotechsektor. So gelang es dem, zwischenzeitlich zu einem Konzern herangewachsenen, Unternehmen
![Gilead Sciences: Remdesivir ist leider kein Allheilmittel](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Gilead Sciences: Remdesivir ist leider kein Allheilmittel
Gilead Sciences (WKN: 885823) ist, langfristig betrachtet, eine der größten Erfolgsgeschichten im Biotechsektor. So gelang es dem, zwischenzeitlich zu einem Konzern herangewachsenen, Unternehmen
![Gilead Sciences: Remdesivir ist leider kein Allheilmittel](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Gilead Sciences: Remdesivir ist leider kein Allheilmittel
Gilead Sciences (WKN: 885823) ist, langfristig betrachtet, eine der größten Erfolgsgeschichten im Biotechsektor. So gelang es dem, zwischenzeitlich zu einem Konzern herangewachsenen, Unternehmen
![Pfizer Invites Public to View and Listen to Webcast of May 15 Conference Call with Analysts to Review Duchenne Muscular Dystrophy (DMD) Data Presentation at ASGCT 2020 Annual Meeting](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Pfizer Invites Public to View and Listen to Webcast of May 15 Conference Call with Analysts to Review Duchenne Muscular Dystrophy (DMD) Data Presentation at ASGCT 2020 Annual Meeting
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts on Friday, May 15, 2020 at 10:00 a.m. EDT. The purpose
![Pfizer Invites Public to View and Listen to Webcast of May 15 Conference Call with Analysts to Review Duchenne Muscular Dystrophy (DMD) Data Presentation at ASGCT 2020 Annual Meeting](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Pfizer Invites Public to View and Listen to Webcast of May 15 Conference Call with Analysts to Review Duchenne Muscular Dystrophy (DMD) Data Presentation at ASGCT 2020 Annual Meeting
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts on Friday, May 15, 2020 at 10:00 a.m. EDT. The purpose
![Humana, Papa and Uber Health Join Industry Leaders to Remind Public They’re “Far from Alone” in Combatting Loneliness and Social Isolation](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Humana, Papa and Uber Health Join Industry Leaders to Remind Public They’re “Far from Alone” in Combatting Loneliness and Social Isolation
Humana Inc. (NYSE: HUM), in partnership with Uber Health, Papa, Coalition to End Social Isolation and Loneliness, and the NASA-funded Translational Research Institute for Space Health (TRISH) today
![Savara Announces Change of Date for 2020 Annual Meeting of Stockholders](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Savara Announces Change of Date for 2020 Annual Meeting of Stockholders
Savara Inc. (Nasdaq: SVRA), an orphan lung disease company, today announced a change in the date, time, and format of its 2020 Annual Meeting of Stockholders due to public health and safety